PRE-CLINICAL STUDY OF EXPECTORANT PROPERTIES OF “AMBROL” TABLETS
DOI:
https://doi.org/10.61841/gs7tb189Keywords:
biopharmaceutical properties,, pharmacological properties,, acute toxicity, specificity,, bioequivalence, in vivo.Abstract
Ambrol is used in conditions where there is a lot of viscous secretion or mucus in the airways. Ambrol is intended for the treatment of acute and chronic infectious respiratory diseases associated with impaired secretion. It stimulates the formation of low viscosity tracheobronchial secretion due to a change in the structure of sputum mucopolysaccharides and increases the secretion of glycoproteins (mucokinetic effect). It stimulates the motor activity of cilia of the ciliated epithelium and improves mucociliary transport, increases the synthesis, secretion of surfactant and blocks its decay. We aimed to study the bioequivalence of the drug “Ambrol”, to study acute toxicity and specific activity.
Downloads
References
[1] Belenky M.L. Elements of a quantitative assessment of the pharmacological effect. L., 1963, -C.81-90.
[2] Burbello A.T., Shabrov A.V. Modern medicines. Moscow, 2007.-S. 283.
[3] Guskova T.A. Toxicology of drugs. Moscow, 2008. - p. 27-30.
[4] Guidelines for the study of the general toxic effects of pharmacological substances. In the Guide to the experimental (preclinical) study of new pharmacological substances. Under the general editorship of a corresponding member of RAMS, professor R. U. Khabriev. Second edition, revised and enlarged. M.: - 2005. - M.: OJSC “Publishing house Medicine”, 2005. p. 41-54.
[5] Guidelines for the study of antitussive and mucolytic drugs / In the Guidelines for conducting preclinical studies of drugs. Edited by Doctor of Medical Sciences A.N. Mironova. // M.: Grif and K, 2012. - S. 502 - 508.
[6] The main methods of statistical processing of the results of pharmacological experiments. // In the Manual on the experimental (preclinical) study of new pharmacological substances under the general editorship of the corresponding member of RAMS, Professor R. U. Khabriev. Second edition, revised and enlarged. M.: - 2005. - M: OJSC “Publishing house” Medicine”, 2005. p. 763-774.
[7] Stefanov A.V. Preclinical studies of drugs, Kiev 2002. p. 91.
[8] Abdijalilova Z. Kh. and YunusovaKh. M. “The substantion of the tablet mass” Ambrol composition choice for tabletizing” // World Journal of Pharmacy and Pharmaceutical Sciences. 2019. Vol.8, Issue 1, p. 260-266. (SJIF Impact Factor 7.421)
[9] Abdijalilova Z. Kh. and YunusovaKh. M. “Study of influence of technological factors on indicators of quality of tablets of secrolitic action” // World Journal of Pharmacy and Pharmaceutical Sciences.-2019.-Vol.9, Issue 1, -p. 373-380. (SJIF Impact Factor 7.632)
[10] Farhan, F.K.Evaluation diffusion coefficient and thermal conductivity for epoxy –nTiO 2(2018) International Journal of Pharmaceutical Research, 10 (1), pp. 277-282.https://www.scopus.com/inward/record.uri?eid=2-s2.0- 85059615739&partnerID=40&md5=377aab3970394ed2cf19aaaa8b0013b9
[11] Gowtham,S., &Karuppusamy,S. (2019). Review of Data Mining Classification Techniques. Bonfring International Journal of Software Engineering and Soft Computing, 9(2), 8-11. doi:10.9756/BIJSESC.9013
[12] Dev,P.,Syiemiong,J.V.,Iawphniaw,O., &Bhutia,R.D., (2019). IOT Based Accident Preventing and Reporting System. Bonfring International Journal of Software Engineering and Soft Computing, 9(2), 12-15. Almurshedi, A., Ismail, A.K. Neural correlation of maturity and perceptual decision making: An event related potential evidence, time-frequency and measure projection analysis (2018) NeuroQuantology, 16 (12), pp. 10-26.
[13] Sonkaya, A.R., Bayazıt, Z.Z. A neurolinguistic investigation of emotional prosody and verbal components of speech (2018) NeuroQuantology, 16 (12), pp. 50-56.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
